Mesotheliomas in Children.
Journal
Advances in anatomic pathology
ISSN: 1533-4031
Titre abrégé: Adv Anat Pathol
Pays: United States
ID NLM: 9435676
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
medline:
9
6
2023
pubmed:
23
5
2023
entrez:
22
5
2023
Statut:
ppublish
Résumé
Mesotheliomas are rare and aggressive tumors that originate from mesothelial cells. Although exceedingly rare, these tumors may occur in children. Different from adult mesotheliomas, however, environmental exposures particularly to asbestos do not appear to play a major role in mesotheliomas in children, in whom specific genetic rearrangements driving these tumors have been identified in recent years. These molecular alterations may increasingly offer opportunities for targeted therapies in the future, which may provide better outcomes for these highly aggressive malignant neoplasms.
Identifiants
pubmed: 37217834
doi: 10.1097/PAP.0000000000000403
pii: 00125480-202307000-00006
doi:
Substances chimiques
Asbestos
1332-21-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
275-279Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Mian I, Abdullaev Z, Morrow B, et al. Anaplastic lymphoma kinase gene rearrangement in children and young adults with mesothelioma. J Thorac Oncol. 2020;15:457–461.
Varan A, Kara A, HalIloIlu M, et al. Malignant mesothelioma in an adolescent boy. Pediatr Int. 1999;41:693–695.
Orbach D, André N, Brecht IB, et al. Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution. Eur J Cancer. 2020;140:63–70.
Grundy GW, Miller RW. Malignant mesothelioma in childhood. Report of 13 cases. Cancer. 1972;30:1216–1218.
Kauffman SL, Stout AP. Mesothelioma in children. Cancer. 1964;17:539–544.
Brecht I, Agaimy A, Besendörfer M, et al. Malignant peritoneal mesothelioma in a 16-year-old girl: presentation of a rare disease. Klin Padiatr. 2012;224:170–173.
Vermersch S, Arnaud A, Orbach D, et al. Multicystic and diffuse malignant peritoneal mesothelioma in children. Pediatr Blood Cancer. 2020;67:e28286.
Argani P, Lian DWQ, Agaimy A, et al. Pediatric mesothelioma with ALK fusions: a molecular and pathologic study of 5 cases. Am J Surg Pathol. 2021;45:653–661.
Moran CA, Albores-Saavedra J, Suster S. Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology. 2008;52:824–830.
Fraire AE, Cooper S, Greenberg SD, et al. Mesothelioma of childhood. Cancer. 1988;62:838–847.
Wolff-Bar M, Dujovny T, Vlodavsky E, et al. An 8-year-old child with malignant deciduoid mesothelioma of the abdomen: report of a case and review of the literature. Pediatr Dev Pathol. 2015;18:327–330.
Haliloglu M, Hoffer FA, Fletcher BD. Malignant peritoneal mesothelioma in two pediatric patients: MR imaging findings. Pediatr Radiol. 2000;30:251–255.
Sugalski A, Davis M, Prasannan L, et al. Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child. Pediatr Blood Cancer. 2013;60:146–148.
Aldrian D, Neu N, Oberhuber G, et al. Pediatric malignant peritoneal mesothelioma with meningeal metastasis. J Pediatr Hematol Oncol. 2022;44:e272–e274.
Olmedilla G, Undaondo C, Vasquez W, et al. Metastatic malignant peritoneal mesothelioma mimicking an autoinflammatory syndrome in a 12-year-old boy. Pediatr Dev Pathol. 2021;24:478–483.
Oberto C, Schwarz KB, Zambidis E, et al. Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease. Dig Dis Sci. 2004;49:434–437.
Bellew E, Lee S, Hiren Patel, et al. Pediatric peritoneal epithelial malignant mesothelioma case report. Case Rep Radiol. 2021;2021:5581757.
Abikhzer G, Gourevich K, Arkovitz M, et al. Role of 18 F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma. Clin Nucl Med. 2013;38:e331–e332.
Rosas-Salazar C, Gunawardena SW, Spahr JE. Malignant pleural mesothelioma in a child with ataxia-telangiectasia. Pediatr Pulmonol. 2013;48:94–97.
Loharamtaweethong K, Puripat N, Aoonjai N, et al. Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum. Histopathology. 2016;68:603–607.
Betti M, Aspesi A, Biasi A, et al. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Cancer Lett. 2016;378:120–130.
Mijalovsky A, Halperin D, Perez Y, et al. Malignant peritoneal mesothelioma in an infant with familial ATM mutations. J Pediatr Hematol Oncol. 2018;40:e511–e515.
Sauter JL, Dacic S, Galateau-Salle F, et al. The 2021 WHO Classification of Tumors of the Pleura: advances since the 2015 classification. J Thorac Oncol. 2022;17:608–622.
Tsai LY, Yang YL, Lu MY, et al. Deciduoid mesothelioma of the pleura in an adolescent boy. Pediatr Hematol Oncol. 2010;27:132–137.
Kimpo MS, Francisco KL, Chong QT, et al. Mesothelioma with ALK gene mutations in two pediatric patients: clinical course and outcome. Pediatr Blood Cancer. 2022;69:e29544.
Desmeules P, Joubert P, Zhang L, et al. A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1/FUS-ATF1 fusions. Am J Surg Pathol. 2017;41:980–988.
Ren H, Rassekh SR, Lacson A, et al. Malignant mesothelioma with EWSR1-ATF1 fusion in two adolescent male patients. Pediatr Dev Pathol. 2021;24:570–574.
Weiss SW, Tavassoli FA. Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol. 1988;12:737–746.
Shibayama T, Shimoi T, Mori T, et al. Cytokeratin-positive malignant tumor in the abdomen with EWSR1/FUS-CREB fusion: a clinicopathologic study of 8 cases. Am J Surg Pathol. 2022;46:134–146.
Argani P, Harvey I, Nielsen GP, et al. EWSR1/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities. Mod Pathol. 2020;33:2233–2243.
Thway K, Noujaim J, Zaidi S, et al. Desmoplastic small round cell tumor: pathology, genetics, and potential therapeutic strategies. Int J Surg Pathol. 2016;24:672–684.
Murumägi A, Ungureanu D, Arjama M, et al. STRN-ALK rearranged pediatric malignant peritoneal mesothelioma—functional testing of 527 cancer drugs in patient-derived cancer cells. Transl Oncol. 2021;14:101027.
Petit A, Lantuejoul S, Mc Leer A, et al. Precision medicine at its best: prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib. Pediatr Blood Cancer. 2021;68:e28666.